| 0 |
Adrenocorticotropic Hormone [EPC] |
24 |
0.0274 |
| 1 |
Oxytocic [EPC] |
32 |
0.0107 |
| 2 |
Lipid Emulsion [EPC] |
17 |
0.0065 |
| 3 |
Protease Inhibitor [EPC] |
240 |
0.0054 |
| 4 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
6 |
0.0048 |
| 5 |
Cytochrome P450 3A Inhibitor [EPC] |
255 |
0.0042 |
| 6 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
169 |
0.0035 |
| 7 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
80 |
0.0033 |
| 8 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
3 |
0.0031 |
| 9 |
Human Immunoglobulin G [EPC] |
62 |
0.0030 |
| 10 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
303 |
0.0027 |
| 11 |
Prostaglandin E1 Analog [EPC] |
45 |
0.0027 |
| 12 |
Progesterone [EPC] |
62 |
0.0027 |
| 13 |
Calcitonin [EPC] |
8 |
0.0026 |
| 14 |
Gonadotropin [EPC] |
5 |
0.0026 |
| 15 |
Polyene Antimicrobial [EPC] |
1 |
0.0025 |
| 16 |
Purine Antimetabolite [EPC] |
240 |
0.0025 |
| 17 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
2 |
0.0024 |
| 18 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
59 |
0.0024 |
| 19 |
Vitamin K [EPC] |
20 |
0.0024 |
| 20 |
Prostacycline [EPC] |
2 |
0.0022 |
| 21 |
alpha-1 Adrenergic Agonist [EPC] |
9 |
0.0021 |
| 22 |
Pyrethroid [EPC] |
3 |
0.0017 |
| 23 |
Ergot Derivative [EPC] |
8 |
0.0017 |
| 24 |
Antimycobacterial [EPC] |
38 |
0.0016 |
| 25 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
15 |
0.0016 |
| 26 |
Actinomycin [EPC] |
3 |
0.0014 |
| 27 |
Progestin Antagonist [EPC] |
6 |
0.0013 |
| 28 |
Sulfonamide Antibacterial [EPC] |
5 |
0.0013 |
| 29 |
Erythropoiesis-stimulating Agent [EPC] |
68 |
0.0013 |
| 30 |
Topoisomerase Inhibitor [EPC] |
97 |
0.0013 |
| 31 |
Bile Acid [EPC] |
27 |
0.0012 |
| 32 |
Alkylating Drug [EPC] |
280 |
0.0012 |
| 33 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
25 |
0.0011 |
| 34 |
Asparagine-specific Enzyme [EPC] |
15 |
0.0011 |
| 35 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
22 |
0.0011 |
| 36 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
10 |
0.0011 |
| 37 |
Nitrofuran Antibacterial [EPC] |
19 |
0.0011 |
| 38 |
Parenteral Iron Replacement [EPC] |
14 |
0.0010 |
| 39 |
Vitamin D [EPC] |
293 |
0.0010 |
| 40 |
Typical Antipsychotic [EPC] |
24 |
0.0010 |
| 41 |
Dihydropyridine Calcium Channel Blocker [EPC] |
313 |
0.0010 |
| 42 |
Sulfone [EPC] |
10 |
0.0009 |
| 43 |
Vitamin B12 [EPC] |
295 |
0.0009 |
| 44 |
Surfactant [EPC] |
1 |
0.0009 |
| 45 |
CCR5 Co-receptor Antagonist [EPC] |
2 |
0.0009 |
| 46 |
Interleukin-1 Receptor Antagonist [EPC] |
14 |
0.0008 |
| 47 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
6 |
0.0008 |
| 48 |
CD33-directed Immunoconjugate [EPC] |
3 |
0.0008 |
| 49 |
Glycopeptide Antibacterial [EPC] |
53 |
0.0008 |
| 50 |
General Anesthetic [EPC] |
35 |
0.0008 |
| 51 |
Complement Inhibitor [EPC] |
56 |
0.0008 |
| 52 |
beta-Adrenergic Blocker [EPC] |
238 |
0.0008 |
| 53 |
Mood Stabilizer [EPC] |
164 |
0.0008 |
| 54 |
Vitamin C [EPC] |
304 |
0.0007 |
| 55 |
Corticosteroid [EPC] |
914 |
0.0007 |
| 56 |
Serotonin-3 Receptor Antagonist [EPC] |
95 |
0.0007 |
| 57 |
Microtubule Inhibitor [EPC] |
111 |
0.0007 |
| 58 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
9 |
0.0007 |
| 59 |
Leukocyte Growth Factor [EPC] |
37 |
0.0007 |
| 60 |
Monoamine Oxidase Inhibitor [EPC] |
2 |
0.0007 |
| 61 |
Dopamine-2 Receptor Antagonist [EPC] |
5 |
0.0007 |
| 62 |
Rifamycin Antibacterial [EPC] |
23 |
0.0007 |
| 63 |
Carbonic Anhydrase Inhibitor [EPC] |
13 |
0.0006 |
| 64 |
Anti-epileptic Agent [EPC] |
150 |
0.0006 |
| 65 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
2 |
0.0006 |
| 66 |
Platelet Aggregation Inhibitor [EPC] |
339 |
0.0006 |
| 67 |
Osmotic Diuretic [EPC] |
3 |
0.0006 |
| 68 |
Penem Antibacterial [EPC] |
19 |
0.0006 |
| 69 |
Interferon alfa-2b [EPC] |
1 |
0.0006 |
| 70 |
Serotonin Reuptake Inhibitor [EPC] |
50 |
0.0006 |
| 71 |
Insulin [EPC] |
25 |
0.0005 |
| 72 |
Aminosalicylate [EPC] |
70 |
0.0005 |
| 73 |
Partial Opioid Agonist [EPC] |
49 |
0.0005 |
| 74 |
Barbiturate [EPC] |
6 |
0.0005 |
| 75 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
7 |
0.0005 |
| 76 |
Platinum-based Drug [EPC] |
139 |
0.0005 |
| 77 |
Cholinergic Nicotinic Agonist [EPC] |
31 |
0.0005 |
| 78 |
Lipid-based Polyene Antifungal [EPC] |
6 |
0.0005 |
| 79 |
Atypical Antipsychotic [EPC] |
229 |
0.0005 |
| 80 |
Benzothiazole [EPC] |
1 |
0.0005 |
| 81 |
CD20-directed Cytolytic Antibody [EPC] |
143 |
0.0005 |
| 82 |
Non-Standardized Plant Allergenic Extract [EPC] |
8 |
0.0005 |
| 83 |
Somatostatin Analog [EPC] |
3 |
0.0004 |
| 84 |
Selective T Cell Costimulation Blocker [EPC] |
2 |
0.0004 |
| 85 |
Anthracycline Topoisomerase Inhibitor [EPC] |
1 |
0.0004 |
| 86 |
Alkaloid [EPC] |
11 |
0.0004 |
| 87 |
Antifibrinolytic Agent [EPC] |
4 |
0.0004 |
| 88 |
Bile Acid Sequestrant [EPC] |
5 |
0.0004 |
| 89 |
Nitroimidazole Antimicrobial [EPC] |
27 |
0.0004 |
| 90 |
Adenosine Receptor Agonist [EPC] |
3 |
0.0004 |
| 91 |
Amide Local Anesthetic [EPC] |
35 |
0.0004 |
| 92 |
Neuraminidase Inhibitor [EPC] |
1 |
0.0004 |
| 93 |
Nucleoside Metabolic Inhibitor [EPC] |
106 |
0.0004 |
| 94 |
Antimalarial [EPC] |
4 |
0.0004 |
| 95 |
Antiprotozoal [EPC] |
4 |
0.0004 |
| 96 |
Phosphodiesterase 5 Inhibitor [EPC] |
51 |
0.0004 |
| 97 |
HER2/neu Receptor Antagonist [EPC] |
28 |
0.0004 |
| 98 |
Proton Pump Inhibitor [EPC] |
219 |
0.0004 |
| 99 |
Cannabinoid [EPC] |
3 |
0.0004 |
| 100 |
Calcium [EPC] |
55 |
0.0004 |
| 101 |
Oxazolidinone Antibacterial [EPC] |
11 |
0.0004 |
| 102 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
11 |
0.0003 |
| 103 |
Macrolide Antimicrobial [EPC] |
18 |
0.0003 |
| 104 |
Non-Standardized Insect Allergenic Extract [EPC] |
2 |
0.0003 |
| 105 |
Antiparasitic [EPC] |
2 |
0.0003 |
| 106 |
CD52-directed Cytolytic Antibody [EPC] |
6 |
0.0003 |
| 107 |
Pediculicide [EPC] |
2 |
0.0003 |
| 108 |
Phenothiazine [EPC] |
9 |
0.0003 |
| 109 |
Central Nervous System Stimulant [EPC] |
27 |
0.0003 |
| 110 |
Antimetabolite Immunosuppressant [EPC] |
6 |
0.0003 |
| 111 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
27 |
0.0003 |
| 112 |
Integrin Receptor Antagonist [EPC] |
24 |
0.0003 |
| 113 |
Standardized Insect Venom Allergenic Extract [EPC] |
2 |
0.0003 |
| 114 |
Nitrate Vasodilator [EPC] |
24 |
0.0003 |
| 115 |
Loop Diuretic [EPC] |
123 |
0.0003 |
| 116 |
Azole Antifungal [EPC] |
42 |
0.0003 |
| 117 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
2 |
0.0003 |
| 118 |
Angiotensin 2 Receptor Blocker [EPC] |
84 |
0.0003 |
| 119 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
35 |
0.0003 |
| 120 |
Cardiac Glycoside [EPC] |
18 |
0.0003 |
| 121 |
Catecholamine [EPC] |
20 |
0.0002 |
| 122 |
Vitamin D3 Analog [EPC] |
5 |
0.0002 |
| 123 |
Phenylalanine Metabolizing Enzyme [EPC] |
2 |
0.0002 |
| 124 |
Provitamin D2 Compound [EPC] |
7 |
0.0002 |
| 125 |
Opioid Agonist [EPC] |
64 |
0.0002 |
| 126 |
Insulin Analog [EPC] |
102 |
0.0002 |
| 127 |
Folate Analog Metabolic Inhibitor [EPC] |
98 |
0.0002 |
| 128 |
Ester Local Anesthetic [EPC] |
11 |
0.0002 |
| 129 |
Histamine-2 Receptor Antagonist [EPC] |
72 |
0.0002 |
| 130 |
Osmotic Laxative [EPC] |
63 |
0.0002 |
| 131 |
alpha-Adrenergic Blocker [EPC] |
30 |
0.0002 |
| 132 |
Tetracycline-class Drug [EPC] |
15 |
0.0002 |
| 133 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
19 |
0.0002 |
| 134 |
Tumor Necrosis Factor Blocker [EPC] |
199 |
0.0002 |
| 135 |
Anti-IgE [EPC] |
18 |
0.0002 |
| 136 |
Central alpha-2 Adrenergic Agonist [EPC] |
11 |
0.0002 |
| 137 |
Cholinergic Muscarinic Antagonist [EPC] |
8 |
0.0002 |
| 138 |
Aldosterone Antagonist [EPC] |
31 |
0.0002 |
| 139 |
Aminoglycoside Antibacterial [EPC] |
9 |
0.0002 |
| 140 |
Polyene Antifungal [EPC] |
8 |
0.0002 |
| 141 |
Interferon beta [EPC] |
41 |
0.0002 |
| 142 |
Histamine-1 Receptor Antagonist [EPC] |
16 |
0.0002 |
| 143 |
Methylxanthine [EPC] |
11 |
0.0002 |
| 144 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
21 |
0.0002 |
| 145 |
Copper-containing Intrauterine Device [EPC] |
9 |
0.0002 |
| 146 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
21 |
0.0002 |
| 147 |
Progestin [EPC] |
50 |
0.0002 |
| 148 |
Interleukin-6 Receptor Antagonist [EPC] |
23 |
0.0002 |
| 149 |
Non-Standardized Chemical Allergen [EPC] |
13 |
0.0002 |
| 150 |
Prostacycline Vasodilator [EPC] |
23 |
0.0002 |
| 151 |
Interleukin-13 Antagonist [EPC] |
1 |
0.0002 |
| 152 |
Factor Xa Inhibitor [EPC] |
44 |
0.0002 |
| 153 |
Thiazide Diuretic [EPC] |
34 |
0.0002 |
| 154 |
Sympathomimetic-like Agent [EPC] |
5 |
0.0002 |
| 155 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
3 |
0.0002 |
| 156 |
P2Y12 Platelet Inhibitor [EPC] |
18 |
0.0002 |
| 157 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
15 |
0.0001 |
| 158 |
Iron Chelator [EPC] |
4 |
0.0001 |
| 159 |
Thrombopoietin Receptor Agonist [EPC] |
2 |
0.0001 |
| 160 |
Janus Kinase Inhibitor [EPC] |
20 |
0.0001 |
| 161 |
Nucleoside Analog Antiviral [EPC] |
10 |
0.0001 |
| 162 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
7 |
0.0001 |
| 163 |
Non-Standardized Food Allergenic Extract [EPC] |
9 |
0.0001 |
| 164 |
Antiarrhythmic [EPC] |
11 |
0.0001 |
| 165 |
Androgen [EPC] |
3 |
0.0001 |
| 166 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
11 |
0.0001 |
| 167 |
Leukotriene Receptor Antagonist [EPC] |
3 |
0.0001 |
| 168 |
Xanthine Oxidase Inhibitor [EPC] |
18 |
0.0001 |
| 169 |
Antirheumatic Agent [EPC] |
11 |
0.0001 |
| 170 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
2 |
0.0001 |
| 171 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
1 |
0.0001 |
| 172 |
Nicotinic Acid [EPC] |
6 |
0.0001 |
| 173 |
Endothelin Receptor Antagonist [EPC] |
19 |
0.0001 |
| 174 |
Kinase Inhibitor [EPC] |
41 |
0.0001 |
| 175 |
Thiazide-like Diuretic [EPC] |
4 |
0.0001 |
| 176 |
Prostaglandin Analog [EPC] |
8 |
0.0001 |
| 177 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
1 |
0.0001 |
| 178 |
Aluminum Complex [EPC] |
2 |
0.0001 |
| 179 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
4 |
0.0001 |
| 180 |
Antisense Oligonucleotide [EPC] |
1 |
0.0001 |
| 181 |
Antidote [EPC] |
5 |
0.0001 |
| 182 |
Expectorant [EPC] |
16 |
0.0001 |
| 183 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
4 |
0.0001 |
| 184 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
2 |
0.0001 |
| 185 |
Interleukin-12 Antagonist [EPC] |
7 |
0.0001 |
| 186 |
CTLA-4-directed Blocking Antibody [EPC] |
3 |
0.0001 |
| 187 |
Aromatase Inhibitor [EPC] |
7 |
0.0001 |
| 188 |
Acetylcholine Release Inhibitor [EPC] |
6 |
0.0001 |
| 189 |
Folate Analog [EPC] |
3 |
0.0001 |
| 190 |
Interleukin-23 Antagonist [EPC] |
13 |
0.0001 |
| 191 |
Estrogen [EPC] |
11 |
0.0001 |
| 192 |
Vitamin A [EPC] |
3 |
0.0001 |
| 193 |
HMG-CoA Reductase Inhibitor [EPC] |
25 |
0.0001 |
| 194 |
Arteriolar Vasodilator [EPC] |
4 |
0.0001 |
| 195 |
Aromatic Amino Acid [EPC] |
3 |
0.0001 |
| 196 |
Recombinant Human Growth Hormone [EPC] |
1 |
0.0000 |
| 197 |
Pyrimidine Synthesis Inhibitor [EPC] |
2 |
0.0000 |
| 198 |
Selective T Cell Costimulation Modulator [EPC] |
6 |
0.0000 |
| 199 |
Sulfonylurea [EPC] |
5 |
0.0000 |
| 200 |
Radiographic Contrast Agent [EPC] |
1 |
0.0000 |
| 201 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
3 |
0.0000 |
| 202 |
GLP-1 Receptor Agonist [EPC] |
14 |
0.0000 |
| 203 |
Interleukin-17A Antagonist [EPC] |
6 |
0.0000 |
| 204 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
5 |
0.0000 |
| 205 |
Retinoid [EPC] |
6 |
0.0000 |
| 206 |
Fluoroquinolone Antibacterial [EPC] |
3 |
0.0000 |
| 207 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
5 |
0.0000 |
| 208 |
Thalidomide Analog [EPC] |
7 |
0.0000 |
| 209 |
RANK Ligand Inhibitor [EPC] |
2 |
0.0000 |
| 210 |
Proteasome Inhibitor [EPC] |
1 |
0.0000 |